{"id":185025,"name":"NATIONAL PSORIASIS FOUNDATION","slug":"national-psoriasis-foundation","state":"OR","country":"United States of America","description":"","totalSpending":1176717.9800000002,"filings":31,"yearlySpending":[{"year":2018,"income":360000},{"year":2019,"income":280000},{"year":2020,"income":210000},{"year":2021,"income":144269},{"year":2022,"income":72063.88},{"year":2023,"income":65885.6},{"year":2024,"income":44499.5},{"year":2025,"income":0}],"issues":["HCR","BUD","MMM","PHA"],"firms":["NATIONAL PSORIASIS FOUNDATION"],"lobbyists":["JESSICA NAGRO","PATRICK STONE","MATTHEW MORAN","HANNAH LYNCH","JASON HARRIS","SARAH BUCHANAN"],"govEntities":["Centers For Disease Control & Prevention (CDC)","HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["Urge Congress to support efforts that increase access to care for individuals living with psoriasis and psoriatic arthritis by supporting the Restoring the Patient's Voice Act (HR 2077). The bill refo","FY19 Appropriations for Psoriatic Disease\nAllocate $1 million in the Fiscal Year 2019 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public ","Urge Congress to support efforts that increase access to care for individuals living with psoriasis and psoriatic arthritis by supporting the Restoring the Patient's Voice Act (HR 2077). The bill refo","In relation to the President's Drug Pricing Blueprint, the NPF advocated for patient priorities as they relate to potential Congressional proposals to move Medicare Part B drugs into Part D, adjust ou","FY19 Appropriations for Psoriatic Disease\nAllocate $1 million in the Fiscal Year 2019 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public "],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}